Dr. Jean Bourbeau, McGill University, Montréal, QC
Learning Objectives
At the end of this session, participants will be able to:
- understand recent updates to the CTS Pharmacotherapy in patients with COPD evidence-based recommendations;
- integrate recommendations for maintenance pharmacotherapy to improve symptoms and quality of life and reduce frequency and severity of AECOPD; and
- discuss Canadian approach and Pharmacotherapy recommendations for COPD patients in view of the recent GOLD update 2019.
